Second generation antipsychotics causing neuroleptic malignant syndrome
| dc.contributor.author | Suraweera, C. | |
| dc.contributor.author | Hanwella, Raveen | |
| dc.contributor.author | De Silva, V. | |
| dc.date.accessioned | 2026-01-14T06:07:14Z | |
| dc.date.issued | 2016 | |
| dc.description.abstract | Neuroleptic malignant syndrome (NMS) is a rare yet potentially lethal medical emergency encountered by psychiatrists. NMS is commonly associated with potent first generation antipsychotics, especially haloperidol and fluphenazine. However, there are many case reports of NMS caused by treatment with second generation antipsychotics (SGA). Mortality from NMS caused by SGA may be less and the presentation may also be different. The article discusses two case reports of neuroleptic malignant syndrome caused by SGA both of which have some unusual features. | |
| dc.identifier.citation | Suraweera, C., Hanwella, R., & De Silva, V. (2016). Second generation antipsychotics causing neuroleptic malignant syndrome. Sri Lanka Journal of Psychiatry, 7(2), 20-22. https://doi.org/10.4038/sljpsyc.v7i2.8115 | |
| dc.identifier.doi | 10.4038/sljpsyc.v7i2.8115 | |
| dc.identifier.uri | https://doi.org/10.4038/sljpsyc.v7i2.8115 | |
| dc.identifier.uri | https://archive.cmb.ac.lk/handle/70130/8449 | |
| dc.language.iso | en | |
| dc.publisher | Sri Lanka Journal of Psychiatry | |
| dc.relation.ispartof | Sri Lanka Journal of Psychiatry | |
| dc.subject | Neuroleptic malignant syndrome | |
| dc.subject | First generation antipsychotics | |
| dc.subject | Second generation antipsychotics | |
| dc.title | Second generation antipsychotics causing neuroleptic malignant syndrome | |
| dc.type | Article | |
| oaire.citation.issue | 2 | |
| oaire.citation.volume | 7 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Second generation antipsychotics causing neuroleptic malignant syndrome.pdf
- Size:
- 51.75 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description:
